Europe — EMA

Paliperidón Stada (Paliperidone)

Paliperidone, the active ingredient in Paliperidón Stada, is an antipsychotic presented as a tablet for oral use. It treats schizophrenia and schizoaffective disorder in adults.

Paliperidone

Request sourcing

Pack/s

What is Paliperidone?

Paliperidone, the active ingredient in Paliperidón Stada, is an antipsychotic presented as a tablet for oral use. It treats schizophrenia and schizoaffective disorder in adults. GNH USA supplies Paliperidón Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidón Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Paliperidone used for?

Paliperidone is indicated for the treatment of schizophrenia and related psychotic disorders, acting on dopamine pathways in the brain.

- Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Schizoaffective disorder: Improves mood stability and psychotic symptom control. - Bipolar I disorder (maintenance): Contributes to mood‑stabilizing effects. - Psychotic depression: Provides antipsychotic coverage . - Acute dement the

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →